Gita Bhat

433 total citations · 1 hit paper
16 papers, 254 citations indexed

About

Gita Bhat is a scholar working on Oncology, Reproductive Medicine and Surgery. According to data from OpenAlex, Gita Bhat has authored 16 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Reproductive Medicine and 4 papers in Surgery. Recurrent topics in Gita Bhat's work include Ovarian cancer diagnosis and treatment (5 papers), PARP inhibition in cancer therapy (4 papers) and Intestinal and Peritoneal Adhesions (3 papers). Gita Bhat is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), PARP inhibition in cancer therapy (4 papers) and Intestinal and Peritoneal Adhesions (3 papers). Gita Bhat collaborates with scholars based in Canada, India and Spain. Gita Bhat's co-authors include Amit M. Oza, Ainhoa Madariaga, Marjan Rouzbahman, M. Babu, D. Lokanatha, Govind Babu, Katherine Karakasis, Linu Abraham Jacob, KC Lakshmaiah and R. S. Jayshree and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and Nature Reviews Clinical Oncology.

In The Last Decade

Gita Bhat

15 papers receiving 249 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heterogeneity and treatment landscape of ovarian carcinoma

2023 96 citations Ainhoa Madariaga, Gita Bhat et al. Nature Reviews Clinical Oncology profile →

Peers

Gita Bhat

ONCOL

IMMUN

PRM

Juliane Liberto United States

Ángeles Montero United Kingdom

Ömer Topalak Türkiye

Takako Miyamura Japan

Nikolaos J. Tsagarakis Greece

Ce Bian China

M.B. Atkins United States

Francesca Nesi Italy

Radheshyam Naik India

Stefan Gysler United States

Juliane Liberto United States

Gita Bhat

63 ×0.7

ONCOL

30 ×0.5

54 ×0.9

IMMUN

116 ×2.1

48 ×1.5

PRM

Citations per year, relative to Gita Bhat Gita Bhat (= 1×) peers Juliane Liberto

Countries citing papers authored by Gita Bhat

Since Specialization

Citations

This map shows the geographic impact of Gita Bhat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gita Bhat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gita Bhat more than expected).

Fields of papers citing papers by Gita Bhat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gita Bhat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gita Bhat. The network helps show where Gita Bhat may publish in the future.

Co-authorship network of co-authors of Gita Bhat

This figure shows the co-authorship network connecting the top 25 collaborators of Gita Bhat. A scholar is included among the top collaborators of Gita Bhat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gita Bhat. Gita Bhat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Mitric, Cristina, et al.. (2023). Gestational trophoblastic neoplasia: does centralization of care impact clinical management?. International Journal of Gynecological Cancer. 33(11). 1724–1732. 2 indexed citations

Madariaga, Ainhoa, et al.. (2023). Heterogeneity and treatment landscape of ovarian carcinoma. Nature Reviews Clinical Oncology. 20(12). 820–842. 96 indexed citations breakdown →

Bhat, Gita, et al.. (2022). Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management Challenges. International Journal of Women s Health. Volume 14. 1849–1862. 4 indexed citations

Lheureux, Stéphanie, Gita Bhat, Ilaria Colombo, et al.. (2022). Pembrolizumab, maveropepimut-S, and low-dose cyclophosphamide in advanced epithelial ovarian cancer: Results from phase 1 and expansion cohort of PESCO trial.. Journal of Clinical Oncology. 40(16_suppl). 5505–5505. 8 indexed citations

Madariaga, Ainhoa, Gita Bhat, Michelle Wilson, et al.. (2021). Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferences. American Journal of Obstetrics and Gynecology. 225(6). 658.e1–658.e9. 5 indexed citations

Bhat, Gita, Katherine Karakasis, & Amit M. Oza. (2020). Measuring Quality of Life in Ovarian Cancer Clinical Trials—Can We Improve Objectivity and Cross Trial Comparisons?. Cancers. 12(11). 3296–3296. 11 indexed citations

Bhat, Gita, Amit M. Oza, Neesha C. Dhani, et al.. (2020). Proactive inter-professional program to manage malignant bowel obstruction (MBO) in women with advanced gynecological cancer: Improving quality of care, education and awareness of malignant bowel obstruction among patients and health care providers. Gynecologic Oncology. 159. 55–56.

Lee, Yeh Chen, Valerie Bowering, Lisa Wang, et al.. (2020). Risk stratified multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program for women with gynecological cancers: Preliminary results from a prospective single-center study.. Journal of Clinical Oncology. 38(15_suppl). 6062–6062. 1 indexed citations

Lheureux, Stéphanie, Ana Oaknin, Swati Garg, et al.. (2019). Evolve: A post PARP inhibitor clinical translational phase II trial of cediranib-olaparib in ovarian cancer—A Princess Margaret Consortium – GCIG Phase II Trial.. Journal of Clinical Oncology. 37(15_suppl). 5521–5521. 13 indexed citations

10.

Bonilla, Luisa, Amit M. Oza, Stéphanie Lheureux, et al.. (2019). Clinical outcome of sequential chemotherapy after immune checkpoint inhibitors in advanced ovarian cancer.. Journal of Clinical Oncology. 37(15_suppl). 5580–5580. 2 indexed citations

11.

Appaji, L., et al.. (2017). Atypical teratoid rhabdoid tumor of the central nervous system: Case series from a regional Tertiary Care Cancer Centre in South India. Journal of Cancer Research and Therapeutics. 13(6). 1015–1022. 4 indexed citations

12.

Bhat, Gita, et al.. (2016). Cancer-associated thrombotic microangiopathy. ecancermedicalscience. 10. 649–649. 41 indexed citations

13.

Babu, Govind, M. Babu, D. Lokanatha, & Gita Bhat. (2016). Outcomes, cost comparison, and patient satisfaction during long-term central venous access in cancer patients: Experience from a Tertiary Care Cancer Institute in South India. Indian Journal of Medical and Paediatric Oncology. 37(4). 232–238. 22 indexed citations

14.

Babu, K Govind, et al.. (2016). Acute Coronary Syndrome Manifesting as an Adverse Effect of All-trans-Retinoic Acid in Acute Promyelocytic Leukemia: A Case Report with Review of the Literature and a Spotlight on Management. Case Reports in Oncological Medicine. 2016. 1–9. 6 indexed citations

15.

Babu, Govind, D. Lokanatha, KC Lakshmaiah, et al.. (2016). Bloodstream infections in febrile neutropenic patients at a tertiary cancer institute in South India: A timeline of clinical and microbial trends through the years. Indian Journal of Medical and Paediatric Oncology. 37(3). 174–182. 31 indexed citations

16.

Bhat, Gita, et al.. (2002). Granulomatous angiitis of the central nervous system associated with herpes zoster.. PubMed. 50. 977–8. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact